Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AMIR REHMAN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1801983176
CMS profile
699926
Location
ALEXANDRIA, VA

General Payments · PY2018–2024

$10,701.65

  • Reported across 351 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$956.76

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $956.76 37

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,657.80 54
PY2019 $1,845.19 46
PY2020 $579.36 20
PY2021 $1,336.21 49
PY2022 $2,289.75 79
PY2023 $2,036.58 66
PY2024 $956.76 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $23.24 01/04/2024 Food and Beverage Undisputed 01/23/2026 1105933680 CMS
ABBVIE INC. $20.62 01/22/2024 Food and Beverage Undisputed 01/23/2026 1105933682 CMS
ABBVIE INC. $26.50 02/17/2024 Food and Beverage Undisputed 01/23/2026 1105933684 CMS
ABBVIE INC. $25.22 02/27/2024 Food and Beverage Undisputed 01/23/2026 1105933686 CMS
ABBVIE INC. $17.78 03/14/2024 Food and Beverage Undisputed 01/23/2026 1105933688 CMS
ABBVIE INC. $18.26 04/02/2024 Food and Beverage Undisputed 01/23/2026 1105933690 CMS
ABBVIE INC. $16.98 04/02/2024 Food and Beverage Undisputed 01/23/2026 1105933692 CMS
ABBVIE INC. $19.01 04/23/2024 Food and Beverage Undisputed 01/23/2026 1105933694 CMS
ABBVIE INC. $20.58 07/01/2024 Food and Beverage Undisputed 01/23/2026 1105933696 CMS
ABBVIE INC. $19.71 08/13/2024 Food and Beverage Undisputed 01/23/2026 1105933698 CMS
ABBVIE INC. $15.79 09/26/2024 Food and Beverage Undisputed 01/23/2026 1105933700 CMS
ABBVIE INC. $26.27 10/15/2024 Food and Beverage Undisputed 01/23/2026 1105933702 CMS
ABBVIE INC. $14.73 11/26/2024 Food and Beverage Undisputed 01/23/2026 1105933704 CMS
Alkermes, Inc. $29.06 12/16/2024 Food and Beverage Undisputed 01/23/2026 1120579813 CMS
Axsome Therapeutics, Inc. $27.69 01/26/2024 Food and Beverage Undisputed 01/23/2026 1148263323 CMS
Axsome Therapeutics, Inc. $29.73 03/19/2024 Food and Beverage Undisputed 01/23/2026 1148263325 CMS
Axsome Therapeutics, Inc. $24.17 04/29/2024 Food and Beverage Undisputed 01/23/2026 1148263327 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.70 03/07/2024 Food and Beverage Undisputed 01/23/2026 1143305203 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.47 04/24/2024 Food and Beverage Undisputed 01/23/2026 1143305207 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.23 05/08/2024 Food and Beverage Undisputed 01/23/2026 1143305211 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.96 07/03/2024 Food and Beverage Undisputed 01/23/2026 1143305214 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.19 09/18/2024 Food and Beverage Undisputed 01/23/2026 1143305218 CMS
Janssen Pharmaceuticals, Inc $33.58 12/12/2024 Food and Beverage Undisputed 01/23/2026 1078222647 CMS
Lundbeck LLC $31.85 09/23/2024 Food and Beverage Undisputed 01/23/2026 1145960408 CMS
Otsuka America Pharmaceutical, Inc. $15.97 03/06/2024 Food and Beverage Undisputed 01/23/2026 1118968203 CMS
Otsuka America Pharmaceutical, Inc. $17.22 04/30/2024 Food and Beverage Undisputed 01/23/2026 1118968205 CMS
Otsuka America Pharmaceutical, Inc. $23.32 06/11/2024 Food and Beverage Undisputed 01/23/2026 1118968207 CMS
Otsuka America Pharmaceutical, Inc. $24.47 08/15/2024 Food and Beverage Undisputed 01/23/2026 1118968209 CMS
Supernus Pharmaceuticals, Inc. $155.66 01/16/2024 Food and Beverage Undisputed 01/23/2026 1147879981 CMS
Supernus Pharmaceuticals, Inc. $20.76 06/03/2024 Food and Beverage Undisputed 01/23/2026 1147775623 CMS
Supernus Pharmaceuticals, Inc. $21.77 07/03/2024 Food and Beverage Undisputed 01/23/2026 1147775625 CMS
Supernus Pharmaceuticals, Inc. $22.42 08/10/2024 Food and Beverage Undisputed 01/23/2026 1147879979 CMS
Supernus Pharmaceuticals, Inc. $22.32 10/10/2024 Food and Beverage Undisputed 01/23/2026 1147879977 CMS
Supernus Pharmaceuticals, Inc. $13.47 12/03/2024 Food and Beverage Undisputed 01/23/2026 1147775619 CMS
Supernus Pharmaceuticals, Inc. $20.09 12/03/2024 Food and Beverage Undisputed 01/23/2026 1147775621 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.00 02/01/2024 Food and Beverage Undisputed 01/23/2026 1137661052 CMS
Takeda Pharmaceuticals U.S.A., Inc. $29.97 04/18/2024 Food and Beverage Undisputed 01/23/2026 1137661054 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.